Japan ACP for Swiss Manufacturers: Non-Resident Importer Setup Under the Japan-Switzerland Economic Partnership Agreement (2026)

Switzerland sits outside the European Union, and Swiss manufacturers exporting to Japan, whether precision instruments, pharmaceuticals, watches, or specialty machinery, do not qualify for...

Switzerland sits outside the European Union, and Swiss manufacturers exporting to Japan, whether precision instruments, pharmaceuticals, watches, or specialty machinery, do not qualify for preference under the EU-Japan Economic Partnership Agreement (EPA) regardless of how closely a Swiss product resembles one made just across the border in an EU member state. Japan and Switzerland negotiated their own bilateral agreement, the Japan-Switzerland Economic Partnership Agreement (日・スイス経済連携協定), which entered into force on 1 September 2009, well before the EU-Japan EPA existed. A Swiss manufacturer with no Japan-registered office faces the same underlying structural question every non-resident exporter faces: who is named as the legal importer on the Japan import declaration (輸入申告), and how does that party establish eligibility for preferential tariff treatment. This post covers the Attorney for Customs Procedures (税関事務管理人, commonly abbreviated ACP) structure for Swiss manufacturers and where it fits alongside the country's more specialized product-compliance categories.

Switzerland Is Not Covered by the EU-Japan EPA

This is worth stating plainly because the assumption otherwise is common and costly. Switzerland is not an EU member state and has never been party to the EU-Japan EPA. A Swiss manufacturer cannot claim EU-Japan EPA preferential rates on any shipment into Japan, and no amount of similarity between a Swiss product and an EU-origin equivalent changes that. The Japan-Switzerland EPA is the only bilateral framework available to Swiss-origin goods, and it has its own rules of origin, its own origin declaration mechanics, and its own tariff schedule, negotiated independently of the EU-Japan agreement that came more than eight years later.

The Structural Problem: No Japan Entity, No Direct Filing

A Swiss manufacturer without a Japan-registered office, residence, or address cannot file a Japan import declaration in its own name. Two distinct structures resolve this, and they are not interchangeable framings of the same service.

IOR (Aplash as Importer of Record). Aplash purchases the goods from the Swiss manufacturer and clears them through Japan Customs (税関) in Aplash's own name, becoming the named importer on the declaration. Because Aplash is the importer of record, Aplash is the party that would claim Japan-Switzerland EPA preference on a qualifying shipment, and the tariff benefit is reflected in the cost structure of the onward resale to the Japan buyer rather than appearing on the Swiss manufacturer's own books. IOR suits a manufacturer that wants no Japan customs identity at all and sells through a Japan distributor or buyer who is expected to carry the import role.

ACP (Swiss Manufacturer as Importer via Attorney for Customs Procedures). Under the Customs Act (関税法) provision governing resident-agent appointment for non-resident importers, reinforced by the October 2023 reform requiring the party with actual disposal authority (処分権限) over the goods to be the named importer, a Swiss manufacturer can remain the legal importer named on its own Japan import declaration. The manufacturer appoints Aplash as its Japan-resident agent, the 税関事務管理人, to handle customs procedures on its behalf. Aplash does not take title to the goods and does not become the importer under this structure; that role belongs to IOR instead. Because the Swiss manufacturer is the named importer, the manufacturer, not Aplash, claims Japan-Switzerland EPA preference directly on its own declaration, and the manufacturer is also the party positioned to recover Japan consumption tax, covered below. ACP is available only while the manufacturer remains a non-resident of Japan: no Japan address, residence, or office. A manufacturer with an incorporated Japan entity is its own importer and engages a licensed customs broker (通関業者) directly.

The choice depends on the manufacturer's Japan distribution arrangement, its appetite for holding a Japan tax and customs identity, and whether it wants to own the EPA duty savings and JCT recovery position directly or hand the entire import process to a counterparty further down the chain.

Japan-Switzerland EPA Origin Procedure

A Swiss manufacturer claiming EPA preference as the named importer under ACP must support the claim with an origin declaration prepared under the Japan-Switzerland EPA's own terms, distinct from both the EU-Japan EPA and the UK-Japan Comprehensive Economic Partnership Agreement, even where drafting conventions across Japan's various EPAs look broadly similar. In general terms:

(a) The exporter (the Swiss manufacturer or its authorized representative) prepares an origin declaration in the form the Japan-Switzerland EPA prescribes, on the commercial invoice or another qualifying commercial document.

(b) The origin declaration must exist before the goods ship; it cannot be produced retroactively once Japan Customs clearance has already occurred.

(c) The goods must satisfy the Japan-Switzerland EPA's own product-specific rules of origin for the relevant tariff heading. Origin is not automatic on the basis that manufacturing took place in Switzerland; the applicable origin criterion and whether the good qualifies for a preferential rate at all depend on the specific HS classification of the product and must be confirmed on a per-product basis.

Because the Japan-Switzerland EPA's tariff schedule and rules of origin are structured by HS heading, and because rates and origin tests vary meaningfully across product categories from precision instruments to pharmaceutical ingredients to finished watches, this guide does not assert a specific duty rate, origin threshold, or tariff-line outcome. Confirm the applicable rule against the agreement text and the good's own classification before the first shipment.

Swiss Categories Where ACP Recurs

Three Swiss export categories come up disproportionately often in Japan import planning, each with its own compliance layer beyond the customs declaration itself.

Precision instruments and specialty machinery. Swiss manufacturers of measurement, testing, and precision manufacturing equipment frequently sell into Japan's electronics, automotive, and life-sciences manufacturing base as B2B capital equipment. These shipments typically involve straightforward customs classification, but exporters should confirm early whether any component of the equipment intersects with Japan's Radio Act (電波法) certification requirements for wireless-enabled instruments, or with Japan's export-control equivalent screening on the Swiss side for dual-use technical equipment, before assuming a routine customs process applies.

Pharmaceuticals and specialty chemicals. Switzerland's pharmaceutical and life-sciences manufacturing base is substantial, and importing finished pharmaceutical products or active ingredients into Japan sits under the Pharmaceuticals and Medical Devices Act (医薬品医療機器等法, commonly known as the PMD Act) in addition to ordinary customs procedures. ACP resolves the customs-declaration layer; it does not substitute for the separate PMD Act registration and approval pathway that governs whether the product itself may be marketed and sold in Japan at all. The two processes run in parallel and should be scoped together, not sequentially, given typical PMD Act review timelines.

Watches, jewelry, and other high-value luxury goods. Swiss watchmaking is one of the most recognizable Swiss export categories into Japan, and high-value goods introduce their own valuation and documentation scrutiny at the border, independent of the EPA preference question. Accurate, defensible customs valuation matters more, not less, once meaningful duty savings are at stake under a preferential claim, since an origin claim invites closer review of the declared value alongside it.

JCT Recovery for Swiss Manufacturers Under ACP

Under ACP, the Swiss manufacturer is the importer of record and pays Japan consumption tax (消費税, JCT) at the border on import clearance. That tax is not a permanent cost if the following registration chain is completed:

(a) ACP appointment with Japan Customs. Aplash files the 税関事務管理人届出書 on the manufacturer's behalf, establishing the manufacturer as the named importer under the Customs Act.

(b) Appointment of a consumption tax payment administrator (消費税の納税管理人) with Japan's National Tax Agency. The manufacturer appoints a Japan-resident party, a role Aplash can fill directly, giving the manufacturer a tax-side presence in Japan capable of filing consumption tax returns.

(c) Registration as a Qualified Invoice Issuer (適格請求書発行事業者) under Japan's Qualified Invoice System, where the manufacturer conducts B2B sales in Japan. This registration is what makes import JCT paid at the border creditable against output JCT on the manufacturer's Japan sales.

Without all three registrations, import JCT sits outside the manufacturer's Japan tax position as an unrecoverable cost. With all three in place, it offsets against output tax through the manufacturer's own JCT filings, prepared for the substantive tax computation and return by a licensed tax accountant (税理士).

Common Mistakes Swiss Manufacturers Make

Assuming EU-Japan EPA terms apply by proximity or similarity. They do not. Switzerland was never a party to the EU-Japan EPA, and every Swiss-origin shipment claiming preference must be assessed under the Japan-Switzerland EPA specifically.

Treating ACP as a substitute for product-specific regulatory approval. ACP resolves who is named as importer and how customs procedures are handled. It does not replace PMD Act registration for pharmaceutical products, Radio Act certification for wireless-enabled instruments, or any other product-category approval that governs whether the goods may be sold in Japan at all.

Filing before the ACP appointment is on record. The 税関事務管理人届出書 cannot be filed retroactively; any shipment cleared before the appointment is registered with Japan Customs is declared under a different importer identity.

Skipping one of the three JCT registration steps. Holding ACP status alone, without the consumption tax payment administrator appointment and Qualified Invoice Issuer registration, leaves import JCT stranded as a permanent cost rather than a recoverable credit.

Assuming a specific duty rate or origin rule applies without checking the product's HS classification. Japan-Switzerland EPA preferential rates and origin criteria vary by tariff heading; confirm the applicable rule for the specific product before the first shipment, not after.

Timeline: What to Allow

ACP registration with Japan Customs typically runs several weeks from the date the completed 税関事務管理人届出書 is filed. Swiss-side origin documentation preparation, including confirming the applicable Japan-Switzerland EPA rule of origin for the product's HS classification, should proceed in parallel rather than after the ACP filing. For pharmaceutical or medical-adjacent products, the separate PMD Act pathway typically requires the longest lead time in the overall project plan and should be scoped first, with ACP and customs planning built around it rather than the reverse.

Conclusion

The Japan-Switzerland EPA gives Swiss manufacturers their own dedicated, long-standing preferential tariff route into Japan, entirely independent of the EU-Japan EPA that many Swiss exporters mistakenly assume covers them. Combined with an ACP appointment, a Swiss manufacturer can hold the Japan importer identity itself, claim EPA preference directly, and recover Japan consumption tax, all without establishing a Japan entity.

For the broader European framework this guide sits alongside, see our ACP for European manufacturers guide. For Swiss watch, jewelry, and luxury-goods exporters specifically, see our IOR for luxury goods guide. For Swiss pharmaceutical and life-sciences manufacturers hiring Japan-based staff alongside their import structure, see our EOR for pharma and biotech guide.


This article is informational only and does not constitute legal, tax, or regulatory advice. Consult a qualified advisor before acting on the content. Last updated: 2026-07.

Our integrated ecosystem enables us to provide world-class corporate services efficiently

Learn More